The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Adoptive Cellular ImmunOthersapy Market Research Report 2025
Synopsis
Adoptive cellular immunity is the transfer of lymphocytes from the donor to the recipient to enhance its cellular immunity.
The global Adoptive Cellular ImmunOthersapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Adoptive Cellular ImmunOthersapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adoptive Cellular ImmunOthersapy.
Report Scope
The Adoptive Cellular ImmunOthersapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Adoptive Cellular ImmunOthersapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adoptive Cellular ImmunOthersapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARsgen Therapeutics Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity Inc
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis AG
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc
Segment by Type
TIL
LAK
CAR-T
TCR-T
CIK
NK
DC
Others
Segment by Application
Hospital
Cancer Hospital
Centers for Disease Control and Prevention
Rehabilitation Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adoptive Cellular ImmunOthersapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Adoptive cellular immunity is the transfer of lymphocytes from the donor to the recipient to enhance its cellular immunity.
The global Adoptive Cellular ImmunOthersapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Adoptive Cellular ImmunOthersapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adoptive Cellular ImmunOthersapy.
Report Scope
The Adoptive Cellular ImmunOthersapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Adoptive Cellular ImmunOthersapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adoptive Cellular ImmunOthersapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARsgen Therapeutics Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity Inc
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis AG
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc
Segment by Type
TIL
LAK
CAR-T
TCR-T
CIK
NK
DC
Others
Segment by Application
Hospital
Cancer Hospital
Centers for Disease Control and Prevention
Rehabilitation Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adoptive Cellular ImmunOthersapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cellular ImmunOthersapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 TIL
1.2.3 LAK
1.2.4 CAR-T
1.2.5 TCR-T
1.2.6 CIK
1.2.7 NK
1.2.8 DC
1.2.9 Others
1.3 Market by Application
1.3.1 Global Adoptive Cellular ImmunOthersapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Cancer Hospital
1.3.4 Centers for Disease Control and Prevention
1.3.5 Rehabilitation Center
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adoptive Cellular ImmunOthersapy Market Perspective (2019-2030)
2.2 Adoptive Cellular ImmunOthersapy Growth Trends by Region
2.2.1 Global Adoptive Cellular ImmunOthersapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Adoptive Cellular ImmunOthersapy Historic Market Size by Region (2019-2024)
2.2.3 Adoptive Cellular ImmunOthersapy Forecasted Market Size by Region (2025-2030)
2.3 Adoptive Cellular ImmunOthersapy Market Dynamics
2.3.1 Adoptive Cellular ImmunOthersapy Industry Trends
2.3.2 Adoptive Cellular ImmunOthersapy Market Drivers
2.3.3 Adoptive Cellular ImmunOthersapy Market Challenges
2.3.4 Adoptive Cellular ImmunOthersapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cellular ImmunOthersapy Players by Revenue
3.1.1 Global Top Adoptive Cellular ImmunOthersapy Players by Revenue (2019-2024)
3.1.2 Global Adoptive Cellular ImmunOthersapy Revenue Market Share by Players (2019-2024)
3.2 Global Adoptive Cellular ImmunOthersapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adoptive Cellular ImmunOthersapy Revenue
3.4 Global Adoptive Cellular ImmunOthersapy Market Concentration Ratio
3.4.1 Global Adoptive Cellular ImmunOthersapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cellular ImmunOthersapy Revenue in 2023
3.5 Adoptive Cellular ImmunOthersapy Key Players Head office and Area Served
3.6 Key Players Adoptive Cellular ImmunOthersapy Product Solution and Service
3.7 Date of Enter into Adoptive Cellular ImmunOthersapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adoptive Cellular ImmunOthersapy Breakdown Data by Type
4.1 Global Adoptive Cellular ImmunOthersapy Historic Market Size by Type (2019-2024)
4.2 Global Adoptive Cellular ImmunOthersapy Forecasted Market Size by Type (2025-2030)
5 Adoptive Cellular ImmunOthersapy Breakdown Data by Application
5.1 Global Adoptive Cellular ImmunOthersapy Historic Market Size by Application (2019-2024)
5.2 Global Adoptive Cellular ImmunOthersapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Adoptive Cellular ImmunOthersapy Market Size (2019-2030)
6.2 North America Adoptive Cellular ImmunOthersapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Adoptive Cellular ImmunOthersapy Market Size by Country (2019-2024)
6.4 North America Adoptive Cellular ImmunOthersapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adoptive Cellular ImmunOthersapy Market Size (2019-2030)
7.2 Europe Adoptive Cellular ImmunOthersapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Adoptive Cellular ImmunOthersapy Market Size by Country (2019-2024)
7.4 Europe Adoptive Cellular ImmunOthersapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adoptive Cellular ImmunOthersapy Market Size (2019-2030)
8.2 Asia-Pacific Adoptive Cellular ImmunOthersapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Adoptive Cellular ImmunOthersapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Adoptive Cellular ImmunOthersapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adoptive Cellular ImmunOthersapy Market Size (2019-2030)
9.2 Latin America Adoptive Cellular ImmunOthersapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Adoptive Cellular ImmunOthersapy Market Size by Country (2019-2024)
9.4 Latin America Adoptive Cellular ImmunOthersapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adoptive Cellular ImmunOthersapy Market Size (2019-2030)
10.2 Middle East & Africa Adoptive Cellular ImmunOthersapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Adoptive Cellular ImmunOthersapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Adoptive Cellular ImmunOthersapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Company Detail
11.1.2 Amgen Inc Business Overview
11.1.3 Amgen Inc Adoptive Cellular ImmunOthersapy Introduction
11.1.4 Amgen Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.1.5 Amgen Inc Recent Development
11.2 Autolus Therapeutics Plc
11.2.1 Autolus Therapeutics Plc Company Detail
11.2.2 Autolus Therapeutics Plc Business Overview
11.2.3 Autolus Therapeutics Plc Adoptive Cellular ImmunOthersapy Introduction
11.2.4 Autolus Therapeutics Plc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.2.5 Autolus Therapeutics Plc Recent Development
11.3 Beijing Immunochina Medical Science & Technology Co Ltd
11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Detail
11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular ImmunOthersapy Introduction
11.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
11.4 Bellicum Pharmaceuticals Inc
11.4.1 Bellicum Pharmaceuticals Inc Company Detail
11.4.2 Bellicum Pharmaceuticals Inc Business Overview
11.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular ImmunOthersapy Introduction
11.4.4 Bellicum Pharmaceuticals Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.4.5 Bellicum Pharmaceuticals Inc Recent Development
11.5 Bristol-Myers Squibb Co
11.5.1 Bristol-Myers Squibb Co Company Detail
11.5.2 Bristol-Myers Squibb Co Business Overview
11.5.3 Bristol-Myers Squibb Co Adoptive Cellular ImmunOthersapy Introduction
11.5.4 Bristol-Myers Squibb Co Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.5.5 Bristol-Myers Squibb Co Recent Development
11.6 bluebird bio Inc
11.6.1 bluebird bio Inc Company Detail
11.6.2 bluebird bio Inc Business Overview
11.6.3 bluebird bio Inc Adoptive Cellular ImmunOthersapy Introduction
11.6.4 bluebird bio Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.6.5 bluebird bio Inc Recent Development
11.7 CARsgen Therapeutics Ltd
11.7.1 CARsgen Therapeutics Ltd Company Detail
11.7.2 CARsgen Therapeutics Ltd Business Overview
11.7.3 CARsgen Therapeutics Ltd Adoptive Cellular ImmunOthersapy Introduction
11.7.4 CARsgen Therapeutics Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.7.5 CARsgen Therapeutics Ltd Recent Development
11.8 Celgene Corp
11.8.1 Celgene Corp Company Detail
11.8.2 Celgene Corp Business Overview
11.8.3 Celgene Corp Adoptive Cellular ImmunOthersapy Introduction
11.8.4 Celgene Corp Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.8.5 Celgene Corp Recent Development
11.9 Cell Medica Ltd
11.9.1 Cell Medica Ltd Company Detail
11.9.2 Cell Medica Ltd Business Overview
11.9.3 Cell Medica Ltd Adoptive Cellular ImmunOthersapy Introduction
11.9.4 Cell Medica Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.9.5 Cell Medica Ltd Recent Development
11.10 Cellular Biomedicine Group Inc
11.10.1 Cellular Biomedicine Group Inc Company Detail
11.10.2 Cellular Biomedicine Group Inc Business Overview
11.10.3 Cellular Biomedicine Group Inc Adoptive Cellular ImmunOthersapy Introduction
11.10.4 Cellular Biomedicine Group Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.10.5 Cellular Biomedicine Group Inc Recent Development
11.11 Celularity Inc
11.11.1 Celularity Inc Company Detail
11.11.2 Celularity Inc Business Overview
11.11.3 Celularity Inc Adoptive Cellular ImmunOthersapy Introduction
11.11.4 Celularity Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.11.5 Celularity Inc Recent Development
11.12 Celyad SA
11.12.1 Celyad SA Company Detail
11.12.2 Celyad SA Business Overview
11.12.3 Celyad SA Adoptive Cellular ImmunOthersapy Introduction
11.12.4 Celyad SA Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.12.5 Celyad SA Recent Development
11.13 Daiichi Sankyo Co Ltd
11.13.1 Daiichi Sankyo Co Ltd Company Detail
11.13.2 Daiichi Sankyo Co Ltd Business Overview
11.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular ImmunOthersapy Introduction
11.13.4 Daiichi Sankyo Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.13.5 Daiichi Sankyo Co Ltd Recent Development
11.14 Fosun Pharmaceutical AG
11.14.1 Fosun Pharmaceutical AG Company Detail
11.14.2 Fosun Pharmaceutical AG Business Overview
11.14.3 Fosun Pharmaceutical AG Adoptive Cellular ImmunOthersapy Introduction
11.14.4 Fosun Pharmaceutical AG Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.14.5 Fosun Pharmaceutical AG Recent Development
11.15 Gilead Sciences Inc
11.15.1 Gilead Sciences Inc Company Detail
11.15.2 Gilead Sciences Inc Business Overview
11.15.3 Gilead Sciences Inc Adoptive Cellular ImmunOthersapy Introduction
11.15.4 Gilead Sciences Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.15.5 Gilead Sciences Inc Recent Development
11.16 Guangzhou Anjie Biomedical Technology Co Ltd
11.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Detail
11.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
11.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular ImmunOthersapy Introduction
11.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
11.17 Hangzhou Converd Co Ltd
11.17.1 Hangzhou Converd Co Ltd Company Detail
11.17.2 Hangzhou Converd Co Ltd Business Overview
11.17.3 Hangzhou Converd Co Ltd Adoptive Cellular ImmunOthersapy Introduction
11.17.4 Hangzhou Converd Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.17.5 Hangzhou Converd Co Ltd Recent Development
11.18 Hebei Senlang Biotechnology Inc Ltd
11.18.1 Hebei Senlang Biotechnology Inc Ltd Company Detail
11.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview
11.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular ImmunOthersapy Introduction
11.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Development
11.19 HRAIN Biotechnology Co Ltd
11.19.1 HRAIN Biotechnology Co Ltd Company Detail
11.19.2 HRAIN Biotechnology Co Ltd Business Overview
11.19.3 HRAIN Biotechnology Co Ltd Adoptive Cellular ImmunOthersapy Introduction
11.19.4 HRAIN Biotechnology Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.19.5 HRAIN Biotechnology Co Ltd Recent Development
11.20 Juno Therapeutics Inc
11.20.1 Juno Therapeutics Inc Company Detail
11.20.2 Juno Therapeutics Inc Business Overview
11.20.3 Juno Therapeutics Inc Adoptive Cellular ImmunOthersapy Introduction
11.20.4 Juno Therapeutics Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.20.5 Juno Therapeutics Inc Recent Development
11.21 Kite Pharma Inc
11.21.1 Kite Pharma Inc Company Detail
11.21.2 Kite Pharma Inc Business Overview
11.21.3 Kite Pharma Inc Adoptive Cellular ImmunOthersapy Introduction
11.21.4 Kite Pharma Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.21.5 Kite Pharma Inc Recent Development
11.22 Nanjing Legend Biotech Co Ltd
11.22.1 Nanjing Legend Biotech Co Ltd Company Detail
11.22.2 Nanjing Legend Biotech Co Ltd Business Overview
11.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular ImmunOthersapy Introduction
11.22.4 Nanjing Legend Biotech Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.22.5 Nanjing Legend Biotech Co Ltd Recent Development
11.23 NantKwest Inc
11.23.1 NantKwest Inc Company Detail
11.23.2 NantKwest Inc Business Overview
11.23.3 NantKwest Inc Adoptive Cellular ImmunOthersapy Introduction
11.23.4 NantKwest Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.23.5 NantKwest Inc Recent Development
11.24 Nkarta Inc
11.24.1 Nkarta Inc Company Detail
11.24.2 Nkarta Inc Business Overview
11.24.3 Nkarta Inc Adoptive Cellular ImmunOthersapy Introduction
11.24.4 Nkarta Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.24.5 Nkarta Inc Recent Development
11.25 Novartis AG
11.25.1 Novartis AG Company Detail
11.25.2 Novartis AG Business Overview
11.25.3 Novartis AG Adoptive Cellular ImmunOthersapy Introduction
11.25.4 Novartis AG Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.25.5 Novartis AG Recent Development
11.26 Ono Pharmaceutical Co Ltd
11.26.1 Ono Pharmaceutical Co Ltd Company Detail
11.26.2 Ono Pharmaceutical Co Ltd Business Overview
11.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular ImmunOthersapy Introduction
11.26.4 Ono Pharmaceutical Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.26.5 Ono Pharmaceutical Co Ltd Recent Development
11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
11.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Detail
11.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
11.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular ImmunOthersapy Introduction
11.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
11.28 Sorrento Therapeutics Inc
11.28.1 Sorrento Therapeutics Inc Company Detail
11.28.2 Sorrento Therapeutics Inc Business Overview
11.28.3 Sorrento Therapeutics Inc Adoptive Cellular ImmunOthersapy Introduction
11.28.4 Sorrento Therapeutics Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.28.5 Sorrento Therapeutics Inc Recent Development
11.29 Takara Bio Inc
11.29.1 Takara Bio Inc Company Detail
11.29.2 Takara Bio Inc Business Overview
11.29.3 Takara Bio Inc Adoptive Cellular ImmunOthersapy Introduction
11.29.4 Takara Bio Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024)
11.29.5 Takara Bio Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Adoptive Cellular ImmunOthersapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of TIL
Table 3. Key Players of LAK
Table 4. Key Players of CAR-T
Table 5. Key Players of TCR-T
Table 6. Key Players of CIK
Table 7. Key Players of NK
Table 8. Key Players of DC
Table 9. Key Players of Others
Table 10. Global Adoptive Cellular ImmunOthersapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Adoptive Cellular ImmunOthersapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Adoptive Cellular ImmunOthersapy Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Adoptive Cellular ImmunOthersapy Market Share by Region (2019-2024)
Table 14. Global Adoptive Cellular ImmunOthersapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Adoptive Cellular ImmunOthersapy Market Share by Region (2025-2030)
Table 16. Adoptive Cellular ImmunOthersapy Market Trends
Table 17. Adoptive Cellular ImmunOthersapy Market Drivers
Table 18. Adoptive Cellular ImmunOthersapy Market Challenges
Table 19. Adoptive Cellular ImmunOthersapy Market Restraints
Table 20. Global Adoptive Cellular ImmunOthersapy Revenue by Players (2019-2024) & (US$ Million)
Table 21. Global Adoptive Cellular ImmunOthersapy Market Share by Players (2019-2024)
Table 22. Global Top Adoptive Cellular ImmunOthersapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cellular ImmunOthersapy as of 2023)
Table 23. Ranking of Global Top Adoptive Cellular ImmunOthersapy Companies by Revenue (US$ Million) in 2023
Table 24. Global 5 Largest Players Market Share by Adoptive Cellular ImmunOthersapy Revenue (CR5 and HHI) & (2019-2024)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Adoptive Cellular ImmunOthersapy Product Solution and Service
Table 27. Date of Enter into Adoptive Cellular ImmunOthersapy Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Adoptive Cellular ImmunOthersapy Market Size by Type (2019-2024) & (US$ Million)
Table 30. Global Adoptive Cellular ImmunOthersapy Revenue Market Share by Type (2019-2024)
Table 31. Global Adoptive Cellular ImmunOthersapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 32. Global Adoptive Cellular ImmunOthersapy Revenue Market Share by Type (2025-2030)
Table 33. Global Adoptive Cellular ImmunOthersapy Market Size by Application (2019-2024) & (US$ Million)
Table 34. Global Adoptive Cellular ImmunOthersapy Revenue Market Share by Application (2019-2024)
Table 35. Global Adoptive Cellular ImmunOthersapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 36. Global Adoptive Cellular ImmunOthersapy Revenue Market Share by Application (2025-2030)
Table 37. North America Adoptive Cellular ImmunOthersapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Adoptive Cellular ImmunOthersapy Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Adoptive Cellular ImmunOthersapy Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Adoptive Cellular ImmunOthersapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Europe Adoptive Cellular ImmunOthersapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Europe Adoptive Cellular ImmunOthersapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Asia-Pacific Adoptive Cellular ImmunOthersapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 44. Asia-Pacific Adoptive Cellular ImmunOthersapy Market Size by Region (2019-2024) & (US$ Million)
Table 45. Asia-Pacific Adoptive Cellular ImmunOthersapy Market Size by Region (2025-2030) & (US$ Million)
Table 46. Latin America Adoptive Cellular ImmunOthersapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Latin America Adoptive Cellular ImmunOthersapy Market Size by Country (2019-2024) & (US$ Million)
Table 48. Latin America Adoptive Cellular ImmunOthersapy Market Size by Country (2025-2030) & (US$ Million)
Table 49. Middle East & Africa Adoptive Cellular ImmunOthersapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 50. Middle East & Africa Adoptive Cellular ImmunOthersapy Market Size by Country (2019-2024) & (US$ Million)
Table 51. Middle East & Africa Adoptive Cellular ImmunOthersapy Market Size by Country (2025-2030) & (US$ Million)
Table 52. Amgen Inc Company Detail
Table 53. Amgen Inc Business Overview
Table 54. Amgen Inc Adoptive Cellular ImmunOthersapy Product
Table 55. Amgen Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 56. Amgen Inc Recent Development
Table 57. Autolus Therapeutics Plc Company Detail
Table 58. Autolus Therapeutics Plc Business Overview
Table 59. Autolus Therapeutics Plc Adoptive Cellular ImmunOthersapy Product
Table 60. Autolus Therapeutics Plc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 61. Autolus Therapeutics Plc Recent Development
Table 62. Beijing Immunochina Medical Science & Technology Co Ltd Company Detail
Table 63. Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
Table 64. Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular ImmunOthersapy Product
Table 65. Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 66. Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
Table 67. Bellicum Pharmaceuticals Inc Company Detail
Table 68. Bellicum Pharmaceuticals Inc Business Overview
Table 69. Bellicum Pharmaceuticals Inc Adoptive Cellular ImmunOthersapy Product
Table 70. Bellicum Pharmaceuticals Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 71. Bellicum Pharmaceuticals Inc Recent Development
Table 72. Bristol-Myers Squibb Co Company Detail
Table 73. Bristol-Myers Squibb Co Business Overview
Table 74. Bristol-Myers Squibb Co Adoptive Cellular ImmunOthersapy Product
Table 75. Bristol-Myers Squibb Co Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 76. Bristol-Myers Squibb Co Recent Development
Table 77. bluebird bio Inc Company Detail
Table 78. bluebird bio Inc Business Overview
Table 79. bluebird bio Inc Adoptive Cellular ImmunOthersapy Product
Table 80. bluebird bio Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 81. bluebird bio Inc Recent Development
Table 82. CARsgen Therapeutics Ltd Company Detail
Table 83. CARsgen Therapeutics Ltd Business Overview
Table 84. CARsgen Therapeutics Ltd Adoptive Cellular ImmunOthersapy Product
Table 85. CARsgen Therapeutics Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 86. CARsgen Therapeutics Ltd Recent Development
Table 87. Celgene Corp Company Detail
Table 88. Celgene Corp Business Overview
Table 89. Celgene Corp Adoptive Cellular ImmunOthersapy Product
Table 90. Celgene Corp Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 91. Celgene Corp Recent Development
Table 92. Cell Medica Ltd Company Detail
Table 93. Cell Medica Ltd Business Overview
Table 94. Cell Medica Ltd Adoptive Cellular ImmunOthersapy Product
Table 95. Cell Medica Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 96. Cell Medica Ltd Recent Development
Table 97. Cellular Biomedicine Group Inc Company Detail
Table 98. Cellular Biomedicine Group Inc Business Overview
Table 99. Cellular Biomedicine Group Inc Adoptive Cellular ImmunOthersapy Product
Table 100. Cellular Biomedicine Group Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 101. Cellular Biomedicine Group Inc Recent Development
Table 102. Celularity Inc Company Detail
Table 103. Celularity Inc Business Overview
Table 104. Celularity Inc Adoptive Cellular ImmunOthersapy Product
Table 105. Celularity Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 106. Celularity Inc Recent Development
Table 107. Celyad SA Company Detail
Table 108. Celyad SA Business Overview
Table 109. Celyad SA Adoptive Cellular ImmunOthersapy Product
Table 110. Celyad SA Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 111. Celyad SA Recent Development
Table 112. Daiichi Sankyo Co Ltd Company Detail
Table 113. Daiichi Sankyo Co Ltd Business Overview
Table 114. Daiichi Sankyo Co Ltd Adoptive Cellular ImmunOthersapy Product
Table 115. Daiichi Sankyo Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 116. Daiichi Sankyo Co Ltd Recent Development
Table 117. Fosun Pharmaceutical AG Company Detail
Table 118. Fosun Pharmaceutical AG Business Overview
Table 119. Fosun Pharmaceutical AG Adoptive Cellular ImmunOthersapy Product
Table 120. Fosun Pharmaceutical AG Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 121. Fosun Pharmaceutical AG Recent Development
Table 122. Gilead Sciences Inc Company Detail
Table 123. Gilead Sciences Inc Business Overview
Table 124. Gilead Sciences Inc Adoptive Cellular ImmunOthersapy Product
Table 125. Gilead Sciences Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 126. Gilead Sciences Inc Recent Development
Table 127. Guangzhou Anjie Biomedical Technology Co Ltd Company Detail
Table 128. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
Table 129. Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular ImmunOthersapy Product
Table 130. Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 131. Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
Table 132. Hangzhou Converd Co Ltd Company Detail
Table 133. Hangzhou Converd Co Ltd Business Overview
Table 134. Hangzhou Converd Co Ltd Adoptive Cellular ImmunOthersapy Product
Table 135. Hangzhou Converd Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 136. Hangzhou Converd Co Ltd Recent Development
Table 137. Hebei Senlang Biotechnology Inc Ltd Company Detail
Table 138. Hebei Senlang Biotechnology Inc Ltd Business Overview
Table 139. Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular ImmunOthersapy Product
Table 140. Hebei Senlang Biotechnology Inc Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 141. Hebei Senlang Biotechnology Inc Ltd Recent Development
Table 142. HRAIN Biotechnology Co Ltd Company Detail
Table 143. HRAIN Biotechnology Co Ltd Business Overview
Table 144. HRAIN Biotechnology Co Ltd Adoptive Cellular ImmunOthersapy Product
Table 145. HRAIN Biotechnology Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 146. HRAIN Biotechnology Co Ltd Recent Development
Table 147. Juno Therapeutics Inc Company Detail
Table 148. Juno Therapeutics Inc Business Overview
Table 149. Juno Therapeutics Inc Adoptive Cellular ImmunOthersapy Product
Table 150. Juno Therapeutics Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 151. Juno Therapeutics Inc Recent Development
Table 152. Kite Pharma Inc Company Detail
Table 153. Kite Pharma Inc Business Overview
Table 154. Kite Pharma Inc Adoptive Cellular ImmunOthersapy Product
Table 155. Kite Pharma Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 156. Kite Pharma Inc Recent Development
Table 157. Nanjing Legend Biotech Co Ltd Company Detail
Table 158. Nanjing Legend Biotech Co Ltd Business Overview
Table 159. Nanjing Legend Biotech Co Ltd Adoptive Cellular ImmunOthersapy Product
Table 160. Nanjing Legend Biotech Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 161. Nanjing Legend Biotech Co Ltd Recent Development
Table 162. NantKwest Inc Company Detail
Table 163. NantKwest Inc Business Overview
Table 164. NantKwest Inc Adoptive Cellular ImmunOthersapy Product
Table 165. NantKwest Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 166. NantKwest Inc Recent Development
Table 167. Nkarta Inc Company Detail
Table 168. Nkarta Inc Business Overview
Table 169. Nkarta Inc Adoptive Cellular ImmunOthersapy Product
Table 170. Nkarta Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 171. Nkarta Inc Recent Development
Table 172. Novartis AG Company Detail
Table 173. Novartis AG Business Overview
Table 174. Novartis AG Adoptive Cellular ImmunOthersapy Product
Table 175. Novartis AG Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 176. Novartis AG Recent Development
Table 177. Ono Pharmaceutical Co Ltd Company Detail
Table 178. Ono Pharmaceutical Co Ltd Business Overview
Table 179. Ono Pharmaceutical Co Ltd Adoptive Cellular ImmunOthersapy Product
Table 180. Ono Pharmaceutical Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 181. Ono Pharmaceutical Co Ltd Recent Development
Table 182. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Detail
Table 183. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
Table 184. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular ImmunOthersapy Product
Table 185. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 186. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
Table 187. Sorrento Therapeutics Inc Company Detail
Table 188. Sorrento Therapeutics Inc Business Overview
Table 189. Sorrento Therapeutics Inc Adoptive Cellular ImmunOthersapy Product
Table 190. Sorrento Therapeutics Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 191. Sorrento Therapeutics Inc Recent Development
Table 192. Takara Bio Inc Company Detail
Table 193. Takara Bio Inc Business Overview
Table 194. Takara Bio Inc Adoptive Cellular ImmunOthersapy Product
Table 195. Takara Bio Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2019-2024) & (US$ Million)
Table 196. Takara Bio Inc Recent Development
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adoptive Cellular ImmunOthersapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Adoptive Cellular ImmunOthersapy Market Share by Type: 2023 VS 2030
Figure 3. TIL Features
Figure 4. LAK Features
Figure 5. CAR-T Features
Figure 6. TCR-T Features
Figure 7. CIK Features
Figure 8. NK Features
Figure 9. DC Features
Figure 10. Others Features
Figure 11. Global Adoptive Cellular ImmunOthersapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 12. Global Adoptive Cellular ImmunOthersapy Market Share by Application: 2023 VS 2030
Figure 13. Hospital Case Studies
Figure 14. Cancer Hospital Case Studies
Figure 15. Centers for Disease Control and Prevention Case Studies
Figure 16. Rehabilitation Center Case Studies
Figure 17. Others Case Studies
Figure 18. Adoptive Cellular ImmunOthersapy Report Years Considered
Figure 19. Global Adoptive Cellular ImmunOthersapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 20. Global Adoptive Cellular ImmunOthersapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 21. Global Adoptive Cellular ImmunOthersapy Market Share by Region: 2023 VS 2030
Figure 22. Global Adoptive Cellular ImmunOthersapy Market Share by Players in 2023
Figure 23. Global Top Adoptive Cellular ImmunOthersapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cellular ImmunOthersapy as of 2023)
Figure 24. The Top 10 and 5 Players Market Share by Adoptive Cellular ImmunOthersapy Revenue in 2023
Figure 25. North America Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. North America Adoptive Cellular ImmunOthersapy Market Share by Country (2019-2030)
Figure 27. United States Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Canada Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Europe Adoptive Cellular ImmunOthersapy Market Share by Country (2019-2030)
Figure 31. Germany Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. France Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. U.K. Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Italy Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Russia Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Nordic Countries Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Asia-Pacific Adoptive Cellular ImmunOthersapy Market Share by Region (2019-2030)
Figure 39. China Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Japan Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. India Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Australia Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Latin America Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Latin America Adoptive Cellular ImmunOthersapy Market Share by Country (2019-2030)
Figure 47. Mexico Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Brazil Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Adoptive Cellular ImmunOthersapy Market Share by Country (2019-2030)
Figure 51. Turkey Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Amgen Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 54. Autolus Therapeutics Plc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 55. Beijing Immunochina Medical Science & Technology Co Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 56. Bellicum Pharmaceuticals Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 57. Bristol-Myers Squibb Co Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 58. bluebird bio Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 59. CARsgen Therapeutics Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 60. Celgene Corp Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 61. Cell Medica Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 62. Cellular Biomedicine Group Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 63. Celularity Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 64. Celyad SA Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 65. Daiichi Sankyo Co Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 66. Fosun Pharmaceutical AG Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 67. Gilead Sciences Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 68. Guangzhou Anjie Biomedical Technology Co Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 69. Hangzhou Converd Co Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 70. Hebei Senlang Biotechnology Inc Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 71. HRAIN Biotechnology Co Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 72. Juno Therapeutics Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 73. Kite Pharma Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 74. Nanjing Legend Biotech Co Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 75. NantKwest Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 76. Nkarta Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 77. Novartis AG Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 78. Ono Pharmaceutical Co Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 79. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 80. Sorrento Therapeutics Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 81. Takara Bio Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2019-2024)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
